ERBB3 and cancer: HER-3 stained tissue samples were similar to the HER-2 staining pattern and were characterized by distinct heterogeneity or focal expression (75% of tissue specimens had ≤30% of HER-2/HER-3 positive cancer cells) as observed in previously published studies in gastrointestinal cancer [20][23].